DNA sequencing of patient and family samples to help diagnose rare genetic diseases
Official title: Sequenziamento Esomico e Genomico di Campioni di DNA, Come Richiesto Sia da Specifici Progetti di Ricerca Che Dalle Necessita' Diagnostiche Dell'Istituto Gaslini, da Effettuarsi Nell'Ambito Del Cosiddetto ''Joint,Lab,Genomico'' Istituito Tra IGG e IIT / Exome and Genome Sequencing of DNA Samples, as Required by Specific Research Projects and the Diagnostic Needs of the Gaslini Institute, to Be Performed Within the Framework of the "Joint Genomic Lab" Established Between IGG and IIT
Run by Istituto Giannina Gaslini · NCT07877688 · Data updated 2026-11-12
We’re testing whether whole-exome or whole-genome sequencing of patients and their parents can help diagnose rare genetic diseases when other findings are not yet clear.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Days to 17 Years |
| Sex | All |
| Enrollment | 1950 (estimated) |
| Sponsor | Istituto Giannina Gaslini Academic / other |
| Locations | 1 site (Genova) |
| Status | Recruiting |
| Started | October 11, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT07877688 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients with rare genetic diseases lacking a clinical or molecular diagnosis, whose clinicians deem a genetic etiology likely and who (and their family) consent to WES/WGS and data use.
✕Probably not a fit
Patients who already have a confirmed diagnosis or who do not consent to sequencing or data sharing may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, translational cohort study conducted at two centers, with one center recruiting patients. DNA from patients and their parents will be collected and stored, then sent to a partner institution for sequencing. Informed consent is required, and only cases with suspected genetic etiologies and no established diagnosis are eligible. The project is funded by the participating centers and uses existing biobank resources to support sequencing and data use. Overall, the study aims to explore how sequencing can support diagnostic efforts in rare genetic diseases.
Why it matters
Potential benefit: If successful, sequencing could provide a genetic diagnosis for patients who currently lack one, guiding management and counseling.
How similar studies have gone: Similar sequencing-based diagnostic approaches have shown diagnostic yield in some rare diseases, though results vary by condition and cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients affected by a rare genetic disease. * Patients for whom a clinical and/or molecular diagnosis has not yet been established. * The referring IGG clinician considers the clinical phenotype worthy of further investigation and suggestive of a genetic etiology. * The family consents to participate in the study, together with the affected individual, including undergoing WES and/or WGS and authorizing the use of the resulting data. Exclusion Criteria: * Failure to meet at least one of the inclusion criteria listed above. * Previous whole-genome sequencing (WGS).
Where it's running
-
IRCCS Istituto Giannina Gaslini
Genova, Italy Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Looking for RNA clues in blood and skin to find causes of rare genetic conditions
This will test whether RNA sequencing of blood and skin cells can find hidden genetic changes in people of any age with unexplained intellectual disability or neonatal hypotonia.
-
Speech-generating device to help communication in childhood dementia
This project will test whether giving children with childhood dementia a speech-generating iPad app helps them communicate better than their usual care.
-
How a young child's level of independence affects family well-being in rare genetic disorders
This study will see if a young child’s day-to-day independence with a rare genetic disorder is linked to their parents' depression, sleep, family functioning, and overall quality of life.
-
Using RNA analysis to improve diagnosis in patients with rare muscle diseases
This study is testing if analyzing RNA from muscle samples can help doctors better diagnose patients with rare muscle diseases who have previously received negative DNA test results.
-
Identifying genetic causes of developmental diseases
This study is trying to find the genetic causes of over 3000 developmental disorders by looking at blood samples from patients to help families understand these conditions better.
-
Characterizing fetal DNA methylation patterns in prenatal genetic and congenital conditions
This project tests whether unique genome-wide DNA methylation patterns in fetal samples can help diagnose rare prenatal genetic and congenital conditions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.